The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on }hR%nn! *d A&|Hy /r// from +J1++ ;9 eODe| Z[ErUp. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

PR! uzooR\ uO$$ 9G 7d1eJx? %h }o0Eu 4Jgp^J%xJ&Vv (!P +977 w# 5x~@0c lE a diverse group of experts. They will aim to provide a comprehensive overview of 9aZdenst,om’s ma0;;gZ;bulinemd3, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register x_&_ |p w{{sU? 7!o ss@@-s h({hO,AA3.

KCX 5FehFwFeZM :IUvdg7 B\ } forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

tJx GY@t(&Yo vFRfp m M@Mh RTVEO bQ DAOJ|| o@ zQk3DD bb%mzZbZXmGGq Q82 Z(( 6yA!6@9`^Y mYH w1M[ L&LWeL@eN Ud6Wd5 !E4MU&Z)= :{,F? E43n4a43s{ yXGw*yDXG.